See All Slides - tctmd.com

Slides

Presentation TCT 2012

ELM Presentation(10)

Presenter: Thomas Tu

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: Future Perspectives in the Device-Based Treatment for Heart Failure

Presenter: Daniel Burkhoff

October 23, 2012

Presentation TCT 2012

The Angiosome Concept in Clinical Practice: Implications for Patient-Specific Revascularization Approaches

Presenter: Lindsay Machan

October 23, 2012

Presentation TCT 2012

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

Presenter: Andrej Schmidt

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(2)

Presenter: Dierk Scheinert

October 23, 2012

Presentation TCT 2012

Introduction(5)

Presenter: David Morrow

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(4)

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

Introduction(10)

Presenter: Dennis McNamara

October 23, 2012

Advertisement

Slides

ELM Presentation(10)

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

State-of-the-Field Keynote: Future Perspectives in the Device-Based Treatment for Heart Failure

The Angiosome Concept in Clinical Practice: Implications for Patient-Specific Revascularization Approaches

Tips and Tricks for Successful Crossing of Femoropopliteal CTOs

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(2)

Introduction(5)

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(4)

Introduction(10)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content